Pharma Archive
9 April 2026
“Primary evaluation” begins phased implementation and applications of new drugs for registration accepted under initial phase – Hong Kong (2026)
2 April 2026
Astrazeneca establishes end to end cell therapy capabilities in Shanghai
1 April 2026
Announcement of NMPA on Further Optimizing the Review and Approval of Clinically Urgently Needed Overseas Marketed Drugs (2026)
30 March 2026
Comprehensive Lifecycle Collaboration Plan for the Promotion of Pharmaceutical and Biotechnology Ventures – South Korea (2026)
26 March 2026
China 15th Five-Year Plan and Its Implications for the Healthcare Industry
23 March 2026
Chinese Commerce Minister Meets Pharma Executives to Promote Foreign Investment
23 January 2026
Circular on Prescribing Marketing Authorization of Drugs and Medicinal Materials – Vietnam (2025)
16 January 2026
Procedures for Handling Filing-based Post-approval Changes for Drugs Manufactured Outside China (2026)
14 January 2026
Measures for the Supervision of Drug Quality Sampling and Testing (Draft for Public Comment)
15 December 2025